|
Originally published In Press as doi:10.1074/jbc.M005214200 on July 5, 2000
J. Biol. Chem., Vol. 275, Issue 39, 30537-30545, September 29, 2000
Chopper, a New Death Domain of the p75 Neurotrophin Receptor That
Mediates Rapid Neuronal Cell Death*
Elizabeth J.
Coulson ,
Kate
Reid,
Manuel
Baca,
Kylie A.
Shipham,
Sarah M.
Hulett,
Trevor J.
Kilpatrick, and
Perry F.
Bartlett
From the Walter and Eliza Hall Institute of Medical Research, Post
Office, Royal Melbourne Hospital, Victoria 3050, Australia
Received for publication, June 15, 2000, and in revised form, July 3, 2000
 |
ABSTRACT |
The cytoplasmic juxtamembrane region of the p75
neurotrophin receptor (p75NTR) has been found to be
necessary and sufficient to initiate neural cell death. The region was
named "Chopper" to distinguish it from CD95-like death domains. A
29-amino acid peptide corresponding to the Chopper region induced
caspase- and calpain-mediated death in a variety of neural and
non-neural cell types and was not inhibited by signaling through Trk
(unlike killing by full-length p75NTR). Chopper triggered
cell death only when bound to the plasma membrane by a lipid anchor,
whereas non-anchored Chopper acted in a dominant-negative manner,
blocking p75NTR-mediated death both in vitro
and in vivo. Removal of the ectodomain of
p75NTR increased the potency of Chopper activity,
suggesting that it regulates the association of Chopper with downstream
signaling proteins.
 |
INTRODUCTION |
The p75 neurotrophin receptor (p75NTR), a member of
the tumor necrosis factor receptor
(TNFR)1 family, was the first
receptor to be described for nerve growth factor (NGF) (1) and can bind
to each of the neurotrophins (brain-derived neurotrophic factor,
neurotrophin-3, and neurotrophin-4/5) with similar equilibrium
constants (2, 3). Subsequently, the Trk (tyrosine
kinase receptor) family, members of which have varying specificity for each neurotrophin, was described (4). Ligand
binding to a Trk receptor activates a phosphorylation signal cascade,
resulting in cell survival and process outgrowth (4, 5); and
p75NTR has been shown to facilitate Trk signal transduction
by the formation of high affinity neurotrophin receptor complexes
(6).
p75NTR can mediate cellular effects independently of
association with Trk, such as the activation of nuclear factor B
(7-10), c-Jun (10, 11), and ceramide (12, 13). Although
providing a definite function for p75NTR signaling remains
controversial, there is substantial evidence to support the hypothesis
that p75NTR can initiate a neural cell death pathway.
Overexpression of p75NTR increases cell death in
Trk-expressing cells (14-17), whereas lowered expression of
p75NTR decreases neuronal death both in vitro
and in vivo (11, 18-20). Furthermore, the apparent
activation of p75NTR by neurotrophins in cells lacking the
appropriate Trk receptor results in cell death in a number of
experimental paradigms. The addition of NGF to developing chick optic
nuclei or NGF (attached to glass beads) applied to developing chick
retinas leads to increased cell death (21, 22), whereas the addition of
blocking antibodies to either NGF or p75NTR decreases
naturally occurring chick retinal cell death (23). Cultured sympathetic
neurons and proprioceptive neurons also display increased cell death
after the addition of brain-derived neurotrophic factor and NGF,
respectively; and it was again possible to block this cell death by
application of p75NTR antibodies (11, 24). Oligodendrocytes
and Schwann cells also show p75NTR-dependent
cell death after treatment with NGF, provided TrkA is not coexpressed
(8, 25).
p75NTR has sequence similarity to other TNFR family members
both in the cysteine-rich ectodomain and in the cytoplasmic sequence known as a "death domain" (26). Despite the presence of a death domain in p75NTR, there is accumulating evidence that this
region does not mediate the ability of p75NTR to promote
cell death. Unlike the TNFR death domain, the death domain of
p75NTR does not interact with other death domain-containing
proteins (16), does not spontaneously multimerize in solution (27), and
does not function in the same manner (28). Moreover, we have recently
shown that without the juxtamembrane sequence, p75NTR is
unable to induce neuronal cell death, whereas deletion of the death
domain sequence has no effect on the ability of p75NTR to
kill (16).
Little is known about the downstream components of the
p75NTR death signaling pathway, although it is known that
caspases are ultimately activated (see Ref. 29). Bcl-2 does not inhibit
cell death induced by p75NTR (16, 25) and can in fact
promote p75NTR-mediated cell death in some circumstances
(16). In contrast, Bcl-xL can inhibit
p75NTR-mediated cell death (16). Recently, the six
TRAF proteins, which are capable of activating nuclear factor
B, have been shown to associate with various regions of the
p75NTR cytoplasmic domain (30, 31). Two novel zinc finger
proteins, neurotrophin receptor interacting factor and SC-1,
have also been found to interact with the cytoplasmic domains of
p75NTR and appear to mediate cell death (32, 33). However,
the precise role of these proteins in p75NTR death
signaling is unclear at this stage. Further characterization of the
responsible death-inducing portion of p75NTR may ultimately
help to determine the role of these and other p75NTR-interacting proteins in p75NTR and Trk signaling.
To determine how the p75NTR death signal is transduced, the
components within the p75NTR cytoplasmic region required
for death signal initiation were sought. The domain that is both
necessary and sufficient for initiating p75NTR cell death
was found to be the cytoplasmic juxtamembrane 29-amino acid
sequence we have named "Chopper." It was found that membrane attachment was critical for cell death initiated by Chopper and that
the ectodomain regulated Chopper activity. Chopper was shown to kill
via a calpain- and caspase-mediated death pathway that is independent
of Trk signaling and that is present in a variety of cell types.
 |
MATERIALS AND METHODS |
Cell Culture--
Dorsal root ganglia were dissected from
postnatal day 0 C57Bl/6 mice and cultured as described previously (16).
PC12 cells were grown in Dulbecco's modified Eagle's medium
containing 10% fetal bovine serum and 5% horse serum
(Commonwealth Serum Laboratories), differentiated with NGF (50 ng/ml; Peprotech) and serum withdrawal, and cultured for a further 5 days prior to microinjection. Wild-type Schwann cells and the 293T and
M1 cell lines were maintained in Dulbecco's modified Eagle's medium
and 10% fetal bovine serum.
Microinjection and Transfection--
Sensory dorsal root
ganglial neurons, rat PC12 cells, and human 293T fibroblast cells were
microinjected with DNA at individual concentrations ranging from 100 to
20 µg/ml as described previously (16). Unless otherwise stated, DNA
concentrations were 100 µg/ml. Where two plasmids were injected
together, the total DNA concentration did not exceed 220 µg/ml, and
toxicity was not observed at this concentration. Live cells were
identified by their phase-bright morphology and, in some cases,
propidium iodide exclusion.
Transient transfections of PC12, 293T, and wild-type Schwann cells were
performed using Effectine (QIAGEN Inc.), and the numbers of live
GFP-expressing cells were determined by FACS or cell counts. Cell survival of sptc35-transfected cells was compared with cells expressing GFP vectors. M1 cells were treated with 2 µM
Palm29pen, and cell survival was compared with PalmCpen-treated
cells. GFP protein expression levels were determined 24 h after
transfection by FACS. Schwann cells, stably transfected with Bcl-2
(25), were transfected with GFP or c35 by a CaCl2 method
and glycerol shock (34) and then sorted by FACS for GFP expression
after 24 h. Apoptosis was induced in Schwann cells by the addition
of 10 ng/ml NGF in basal medium as described previously (25).
DNA Constructs--
All p75NTR plasmids contain
modified versions of rat p75 cDNA. Expression vectors were either
pPUC9 with a 550-base pair phosphoglycerate kinase
(pgk) promoter (18) or pIRES-EGFP
(CLONTECH). All pPUC9 constructs retain p75
3'-untranslated sequences from the BglII site
(position 1760). p75NTRnc, p75NTRtr, and
p75NTR 35 have been previously described
(16). sptc (signal
peptide-transmembrane-cytoplasmic) constructs were made by fusing the AflIII site (position
208) with the SacII site (position 849) of rat
p75NTR, creating a Trp codon and bringing together
Thr32 and Thr247. sptc35 is truncated with an
I308A substitution. c35 constructs were made by polymerase chain
reaction, amplifying the juxtamembrane 35-amino acid p75NTR
fragment, which was then cloned into the pIRES-EGFP vector
(EcoRI and BamHI sites), followed by introduction
of double-stranded oligonucleotide "fragments" into the
NotI and EcoRI sites, which include a Kozak
sequence and an initiation methionine. The sptc35 Cys-to-Ala mutation
was introduced by polymerase chain
reaction.2 All constructs
were DNA-sequenced; and where possible, protein expression was
determined by immunohistochemistry.
Peptides--
The 35-amino acid peptide corresponding to rat
p75NTR residues 274-308 was purchased from Chiron
(Melbourne, Australia). This sample was ~40% pure, with the
major impurity being a des-Pro 34-residue contaminant. All other
peptides were synthesized in-house using Fmoc amino acids activated
with
O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium hexafluorophosphate. Peptides were synthesized on a Rink amide 4 methylbenzhydrylamine (MBHA) resin support so that all peptides contained a C-terminal amide group. Fluorescein-labeled peptides were
generated by coupling 5- (and 6-)-carboxyfluorescein succinimidyl ester
(Molecular Probes, Inc.) to the amino-terminal end of a resin-bound
peptide prior to its cleavage and deprotection. A palmitoylated analog
of p75NTR (residues 274-302) was prepared by coupling
Fmoc-Lys-( -palmitoyl) to the resin-bound 29-residue peptide,
removing the Fmoc group, and then fluorescein labeling as described
previously. The control peptide, KELPRQPpYFKQNCSQ, was similarly
palmitoylated. Peptides were purified to homogeneity by reverse-phase
HPLC, and their covalent structures were confirmed by matrix-assisted
laser desorption ionization mass spectrometry.
The penetratin peptide, CRQIKIWFPNRRMKWKK (35), contained a
unique cysteine residue at the amino terminus to facilitate conjugation, via a disulfide bond, to p75NTR peptides that
also contained a unique cysteine residue. The penetratin cysteine
residue was activated with 2,2'-dipyridyl disulfide to generate the
S-2-pyridylsulfenyl derivative, and this product was
purified by HPLC. Formation of penetratin-p75NTR peptide
conjugates was achieved by mixing 2 eq of derivatized penetratin with 1 eq of p75NTR peptide in 6 M guanidine
hydrochloride and 100 mM Tris (pH 7.4), incubating for
several hours at room temperature, and then purifying by HPLC.
The caspase inhibitor peptides t-butoxycarbonyl-D-fmk and
benzyloxycarbonyl-DEVD-fmk (Calbiochem) were reconstituted in
Me2SO and diluted in 0.1 M Tris buffer (pH
8.0). The calpain inhibitors N-acetyl-Leu-Leu-norleucinal
and PD150606 (Calbiochem) were reconstituted fresh in
Me2SO. Inhibitors were applied to neurons (3-h
pretreatment) for a total of 5 h, including the 2-h incubation
with 1 µM Chopper peptides, with a final 1%
concentration of Me2SO in all conditions. Cell survival was
determined by phase-bright morphology and propidium iodide exclusion.
Retinal Ganglial Death Assay--
Cell death of retinal ganglia
from developing chicken embryos was quantified using an enzyme
immunoassay for histones (Roche Molecular Biochemicals) as described
previously (22, 36). Using a 30-gauge needle and a Hamilton syringe, 1 µl of solution (100 µM diluted in phosphate-buffered
saline) was injected into the eye vitreous of E4.5-5 fertilized
chicken embryos. The eggs were allowed to develop for a further 24 h, and the retinal ganglial cell layer was dissected from E5.5-6
embryos into phosphate-buffered saline containing Complete protease
inhibitors (Roche Molecular Biochemicals) and homogenized by
trituration through a 25-gauge needle. Cells were lysed and
analyzed according to assay instructions by enzyme-linked immunosorbent
assay measuring relative cell death by absorbance at
405.
 |
RESULTS |
p75NTR Mediates Cell Death through the Cytoplasmic
Juxtamembrane Domain Called Chopper--
To fully characterize the
critical region of the p75NTR cytoplasmic domain that is
both sufficient and necessary to mediate cell death, a series of
expression constructs were made in which one or more protein domains of
rat p75NTR were deleted (Fig.
1A). The ability of the
resulting truncated p75NTR proteins to mediate cell death
was determined by microinjection of these constructs into the nuclei of
freshly isolated sensory neurons cultured in the presence of leukemia
inhibitory factor (LIF) and measuring cell survival over the next
24 h.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Chopper, a small juxtamembrane domain of
p75NTR, is required and sufficient to mediate neuronal
death. A, shown is a schematic of p75NTR
proteins expressed by various expression vectors. Numbers
indicate the amino acids at which the truncated proteins vary from the
full-length protein (see "Materials and Methods"). B,
shown is the survival of sensory neurons in the presence of LIF 16 h after microinjection with various expression constructs at 100 µg/ml. The graph is a compilation from five experiments, standardized
to control vectors ± S.E. *, p < 0.05; ***,
p < 0.001 C, p75NTR-IRES-EGFP
expression constructs were transiently transfected into 293T cells; and
after 24 h, 50,000 PI negative cells were monitored for GFP
expression by FACS. Expression levels did not significantly differ
between constructs of differing sizes.
|
|
Constructs retaining the cytoplasmic juxtamembrane 35- amino acid
domain along with the ectodomain (p75, p75NTRtr) were able
to mediate neuronal death, whereas those lacking this domain
(p75NTRnc, p75NTR 35) were not
(Fig. 1B), a result that is in agreement with earlier findings (16). This indicated that the domain required for
p75NTR death signaling is the juxtamembrane domain and not
the region with homology to the CD95 and TNFR death domains.
To determine whether the ectodomain of p75NTR is necessary
to mediate the death signaling pathway, a construct lacking the
ectodomain (but retaining the signal peptide
sequence, transmembrane domain, and entire 152
amino acid cytoplasmic domain, sptc152) (Fig.
1A) was tested for its ability to kill. It was found that
removal of the ectodomain significantly increased the killing ability and more than doubled the amount of cell death induced by full-length p75NTR (Fig. 1B). The construct was then further
truncated, removing the region with homology to the CD95 death domain
as well as the ectodomain (sptc35) (Fig. 1A), and this was
found to induce significantly more neuronal death compared with
sptc152, killing >90% of the cells within 16 h of microinjection
(Fig. 1B). In contrast to full-length p75NTR
(16), these constructs retained the ability to induce cell death in the
context of NGF-Trk survival signaling (data not shown).
Suprisingly, expression of the juxtamembrane 35-amino acid
p75NTR fragment with no transmembrane sequence (c35) (Fig.
1A) did not promote cell death in the presence of LIF; cells
expressing c35 (confirmed by FLAG epitope staining (data not shown))
survived as well as cells expressing p75NTR with no
cytoplasmic tail (p75NTRnc) (Fig. 1B).
To rule out the possibility that the degree of killing was due to
increased expression of the truncated constructs, each
p75NTR protein was coexpressed with GFP from an internal
ribosome-binding site such that the expression of GFP was proportional
to the expression of p75NTR (see "Materials and
Methods"). 293T cells were transiently transfected with the various
constructs, and the level of GFP expression was determined by FACS. No
significant difference in expression was observed between any of the
various constructs expressing truncated p75NTR forms and
full-length p75NTR-expressing vector (Fig.
1C).
The results indicated that the membrane-linked 35-amino acid domain was
required not only for p75NTR-mediated death signaling, but
was, by itself, sufficient to induce cell death that was of greater
potency than when it was linked to other domains. This killing domain
of p75NTR has been named Chopper to distinguish it from the
CD95 homologous death domain region.
Free Chopper Inhibits p75NTR-mediated Killing--
As
c35 was unable to induce cell death, we examined whether it might act
to inhibit p75NTR-mediated cell death by a
dominant-negative mechanism. When c35 was coexpressed with sptc35 in
neurons, it was found to inhibit cell death in a
dose-dependent fashion (Fig.
2A).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Free Chopper protects neurons from cell
death. A, sensory neurons in LIF were co-injected with
different ratios of the two expression vectors sptc35 and c35, keeping
sptc35 at 20 µg/ml. Survival of neurons injected with 200 µg/ml c35
alone is standardized to 100%. A 1:10 plasmid ratio of sptc35 to c35
resulted in complete protection against sptc35-induced killing after
15 h (mean ± S.E., n = 3). B, rat
Schwann cells treated with NGF showed significant cell death over
24 h, which was inhibited by expression of the c35 construct, with
cell survival not significantly different from GFP-expressing cells
cultured in Dulbecco's modified Eagle's medium (DME) alone
(mean ± S.E., n = 6). C, c35,
p75NTR, and Bcl-2 plasmids were co-injected into sensory
neurons, and survival was assessed after 16 h. Coexpression of c35
inhibited constitutive killing mediated by p75NTR and Bcl-2
overexpression, with cell survival not significantly different from
coexpression of Bcl-2 and c35 (mean ± S.E., n = 2). D, sensory neurons were subject to NGF withdrawal
16 h after microinjection (t = 0), and survival
was monitored for a further 20 h. There was no significant
difference in the amount of cell death after NGF withdrawal (gray
bars) between neurons injected with GFP or c35 constructs,
although significant cell death occurred under both conditions compared
with neurons maintained in NGF (black bars) (mean ± S.E., n = 2). *, p < 0.05.
|
|
To ascertain whether the Chopper sequence also mediates cell death in
other paradigms of p75NTR-mediated death, we tested the
effect of c35 expression in a Schwann cell system where it has been
shown that NGF induces cell death through endogenous p75NTR
(25). Transfected Schwann cells expressing c35 or GFP were plated in
the presence or absence of NGF, and their survival was monitored over a
24-h period. c35 expression was found to significantly abrogate Schwann
cell death, blocking >90% of NGF-induced cell death compared with the
GFP control (Fig. 2B). This strongly suggests that
NGF-induced Schwann cell death is mediated through a
Chopper-dependent pathway.
Previously, we had shown that Bcl-2 enhanced neuronal death mediated by
p75NTR overexpression (16), so the effect of c35 on this
neuronal death pathway was also examined. When c35 was coexpressed with p75NTR and Bcl-2, it again totally abrogated the effects of
p75NTR-mediated killing (Fig. 2C), again
suggesting that this pathway is dependent on Chopper activity.
The ability of c35 to inhibit neuronal cell death due to stress
stimuli, namely NGF withdrawal, was also tested. No increase in
survival of neurons treated with c35 was observed after 48 h (Fig.
2D). This result was consistent with our previous
observation that the death pathway used by cells dying from stress
stimuli is distinct from the p75NTR-mediated death pathway
(16).
Free Chopper Peptides Prevent Death Signaling in Vitro and in
Vivo--
To further examine the requirements for death induction by
the Chopper domain and to confirm the inhibitory action of c35, cell-permeable p75NTR-derived peptides were synthesized.
Due to ease of synthesis, a 29-residue (lacking the 6 carboxyl-terminal amino acids), in addition to the 35-residue
peptide of the Chopper sequence, was synthesized and modified as shown
in Fig. 3A (see "Materials
and Methods"). To facilitate intracellular delivery of synthetic
p75NTR-derived peptides, a 17-residue cell-permeable
penetratin peptide (35) was conjugated to p75NTR peptides
via a disulfide bond (see "Materials and Methods"). This linkage is
stable in the extracellular, but is rapidly reduced once the complex is
internalized, liberating the p75NTR peptide from penetratin
(37).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Construction and uptake of cell-permeable
Chopper peptides. A, peptides were synthesized and
modified in a number of ways as described under "Materials and
Methods." Fluorescein (F) was conjugated to the
c29 Chopper peptides; cell-permeable penetratin peptides (pen)
were linked by a disulfide bond to the peptides. c29 and control
peptide derived from gp130 (PalmC) were also modified by the addition
of a lysine-palmitoyl residue to the amino-terminal end prior to
fluorescein conjugation and penetratin linkage. B, uptake of
the c29pen peptide was dose-dependent. Cells in LIF were
treated with 10 µM or 3 µM peptide
for 30 min and then washed to remove excess peptide. Cell counts were
performed prior to treatment, immediately after washing, and then
during the following 22 h, assessing the percentage of strongly
fluorescent live cells.
|
|
Fluorescein-labeled p75NTR-derived c29 peptide conjugated
to penetratin (c29pen) was rapidly taken up by neurons and was observed throughout the cell, as judged by fluorescence microscopy including confocal imaging (Figs. 3B and
4, A, C, and
E). At a peptide concentration of 10 or 15 µM,
all neurons were found to be fluorescent after 30 min, whereas at 3 µM, <20% of the cells were fluorescent at this time
point (Fig. 3B). Longer treatment of cells with 3 µM peptide (2 h) did, however, result in all cells taking
up the peptide (data not shown). In contrast, no appreciable uptake of non-conjugated peptides (c29) could be detected (Fig. 4, B,
D, and F), even after a 24-h incubation with 15 µM peptide (data not shown). Treatment for up to 2 h
with a 15 µM concentration of the penetratin-linked free
Chopper peptides had no significant effect on neuronal survival after
16 h in either NGF (76.2 ± 7.9%) or LIF (88.3 ± 3%)
compared with untreated cells (86.6 ± 1.8 and 85.4 ± 5.3%,
respectively); however, toxic effects were observed when neurons were
treated with penetratin alone or penetratin-linked peptides at
concentrations >20 µM and applied for >2 h (data not shown).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
Uptake and effect of penetratin-coupled
Chopper peptides. Sensory neurons cultured in the presence of NGF
showed significant uptake of 20 µM penetratin-conjugated,
fluorescein-labeled 29-mer Chopper peptides after 2 h (c29pen)
(A and C), whereas neurons treated with 20 µM penetratin-free c29 peptide showed no evidence of
internal fluorescence after 2 h (B and D).
Fluorescent confocal images confirmed the accumulation of c29 coupled
to penetratin (c29pen) in the cytoplasm of neurons, as seen in this
neuronal cluster (E), and the complete absence of
fluorescence in c29-treated neurons (F) after a 1-h
treatment at 15 µM. Confocal examination of neurons
treated with 2 µM palmitoylated c29pen for 1 h
showed intense fluorescence, which was often associated with membranes and was especially obvious in
membranes that had begun to form large blebs at the surface of neurons
(G, arrows). Other neurons showed accumulation of
fluorescence in vacuoles that appeared to be budding off at the cell
surface (H). By 2 h, many of the neurons that had taken
up the palmitoylated c29pen peptide (J) were dead, as shown
by their crenated and shrunken appearance (I) and the uptake
of propidium iodide into their nuclei (K).
A, B, and I, phase-contrast
micrographs (bar = 50 µm); C,
D, and J, conventional fluorescence micrographs
(bar = 50 µm); E-H, single confocal
fluorescence micrographs (bar = 5 µm).
|
|
To test the ability of these p75NTR peptides to prevent
cell death, neurons were injected with sptc35 or control GFP expression plasmids and then treated for 30 min with 15 µM synthetic
c35-penetratin conjugate (c35pen) or penetratin alone (pen). Neurons
injected with sptc35 and then treated with cell-permeable c35pen
peptide had a significant survival advantage over penetratin-alone
treated cells (Fig. 5A). The
29-residue peptide (c29pen) lacking the 6 carboxyl-terminal residues of
c35 was found to confer equivalent protection against sptc35-mediated
cell death (Fig. 5A).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Free Chopper peptides inhibit neuronal
death. A, 2 h after microinjection of sptc35
constructs into neurons in the presence of LIF, neurons were treated
for 30 min with 10 µM either penetratin alone, c35pen, or
c29pen peptides. The number of live neurons was counted after removal
of peptide from the medium (t = 0) and again after
16 h. Both the c35pen and c29pen peptides gave significant
protection from sptc35 killing in the presence of penetratin.
GFP-expressing, c29pen peptide-treated neurons are standardized to
100% (mean ± S.E., n = 3). B, the
eyes of E4.5 chicks were incubated with 100 µM peptide
for 24 h and then assayed for apoptosis (see "Materials and
Methods"). Degree of cell death is standardized to uninjected eyes.
c29pen-treated retina showed a 40% reduction in cell death compared
with pen- or c29-treated retina. Values indicate means ± S.E. The number of animals is indicated within the bars. *,
p < 0.05; **, p < 0.025; ***,
p < 0.01.
|
|
The free Chopper peptides were then utilized to determine whether the
Chopper domain functions during development of the nervous system.
Developmental cell death of chick retinal ganglial neurons occurs
during early embryogenesis (E3-7) and has been shown to be mediated
through NGF and p75NTR (22, 23). To test if Chopper could
inhibit retinal ganglial cell death, various peptides (pen,
c29pen, and c29) were injected into the vitreous of E4.5 chick eyes
in ovo. At E5.5, the retinal ganglial layer was dissected
from the embryos and analyzed for apoptotic cell death. c29pen was
found to significantly reduce the degree of cell death by 40% (Fig.
5B), indicating that the Chopper domain is involved in
initiating downstream signaling of the p75NTR cell death
pathway during the period of naturally occurring cell death.
Lipid-modified Chopper Peptides Cause Cell Death--
Our
observations that transmembrane Chopper (sptc35) was a potent inducer
of death and that free Chopper specifically inhibited this activity
suggested that both proteins bound to the same accessory protein(s),
but that membrane localization was required to activate the death
pathway. To further explore whether the killing activity of
p75NTR requires the transmembrane sequence or whether
membrane attachment per se is sufficient, lipid-modified
(palmitoylated) forms of pro-survival Chopper peptides were generated
to localize them to the plasma membrane (38, 39). The synthetic 29-mer
Chopper peptide was modified by conjugation of lysine- -palmitoyl and fluorescein moieties to the amino terminus (Palm29pen) (Fig.
3A); and its cellular localization and ability to induce
neuronal death, when delivered as a penetratin conjugate, were examined.
Interestingly, the addition of the lipid group reduced the
concentration of penetratin-linked peptide required for cellular uptake: 97 ± 4.2% of the cells were visibly fluorescent after incubation in 2 µM Palm29pen for 30 min compared with
<20% with c29pen treatment (see Fig. 3B). In contrast to
cells treated with non-palmitoylated peptides (Fig. 4, A,
C, and E), cells treated with Palm29pen showed
visible changes in morphology within 1 h of treatment: the neurons
had large surface vacuoles or "blebbing" (Fig. 4, G and
H) reminiscent of classical apoptosis (40, 41). The
localization of palmitoylated Chopper was throughout the cell, but was
particularly noticeable in the plasma membrane of the vacuoles (Fig.
4G); and fluorescein was highly concentrated in membrane
"blebs" attached to the cell body and neurites (Fig. 4H). In addition, dead cells had morphological changes
consistent with apoptosis (41), including crenated appearance and
condensed, propidium iodide-positive chromatin (Fig. 4, I,
J, and K). Indeed, neurons treated with the
palmitoylated Chopper peptide underwent very rapid cell death within
the 2-h treatment period, in contrast to cells treated with
non-palmitoylated peptides: an unrelated peptide, PalmCpen (derived
from gp130), that was also palmitoylated and conjugated to penetratin
(Fig. 6A), or Palm29, which
was not conjugated to penetratin (data not shown), none of which showed evidence of morphological changes. This suggested that Chopper initiated a death signal shortly after peptide internalization, but
only when it interacted with the plasma membrane. Moreover, it strongly
suggested that the transmembrane sequence of p75NTR was not
important in determining the ability of the Chopper domain to mediate
cell death.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Lipid modification allows Chopper to signal
cell death. A, neurons in NGF were treated with 2 µM peptides over 2 h; and their survival was
assessed before treatment (t = 0), after washing
(t = 2), and after a further 3 h. Palm29pen ( )
caused rapid cell death (p < 0.001) compared with the
control peptides c29pen ( ) and pen ( ) or with the palmitoylation
control PalmCpen ( ) (mean ± S.E., n = 2).
B, sptc35 constructs were microinjected into sensory neurons
in the presence of LIF, and cell survival was assessed after 16 h.
Unlike sptc35, expression of sptc35 C279A (Cys-to-Ala mutation in
Chopper) had no effect on cell viability, with survival not
significantly different from c35-expressing neurons (standardized to
100%) (mean ± S.E., n = 2). ***,
p < 0.001.
|
|
Since p75NTR has been shown to be normally palmitoylated at
cysteine 279, which is within the Chopper domain (42), we examined whether this residue may be critical to killing. Because Palm29pen was
palmitoylated through a modified lysine residue and because the peptide
might be further palmitoylated at cysteine 279 (used for penetratin
conjugation) after reduction of the disulfide bond (Fig.
3A), cysteine 279 was substituted in the sptc35 expression construct with alanine. Unlike sptc35, expression of sptc35 C A in neurons did not induce cell death (Fig. 6B),
indicating that Cys279 is necessary for the cell killing
activity of Chopper.
Chopper Death Signaling Is Independent of Trk and Is Mediated
through Calpains and Caspases--
The ability of palmitoylated
Chopper peptides to kill within 2 h of application suggested that
the downstream components of the death pathway were already present in
the neurons and did not require up-regulated expression for death
induction. To determine whether these components are found specifically
in neurons, the ability of membrane-associated Chopper (expression
constructs and peptides) to kill a range of cell types was determined.
Membrane-associated Chopper was found to kill Schwann cells, 293T
fibroblast cells, and M1 lymphocytes, which do not express Trk
(43-45), as well as sensory neurons and differentiated and
undifferentiated neuroblastoma PC12 cells (see "Materials and
Methods"; data not shown). This implied that the death machinery
utilized by the Chopper sequence was present in a variety of cell types
and was independent of the presence of Trk. Although sptc35 was a
potent inducer of death in 293T cells (29 ± 1%), full-length
p75NTR and p75NTRtr (85 ± 2.6%)
surprisingly did not induce any 293T cell death, even in the presence
of 50 ng/ml NGF, suggesting that a component of p75NTR
activation, present in dorsal root ganglial neurons, is lacking in 293T cells.
Recently, the PEST domain of I B was shown to bind to the
calmodulin-like domain of the large subunit of the µ-calpain
protease, and such interaction, in the presence of calcium, was
sufficient to activate calpain (46). The presence of a PEST domain in
Chopper (47) suggests that calpain binding and activation may possibly occur in p75NTR-mediated cell death. Therefore, the ability
of Chopper to kill in the presence of calpain inhibitors was
determined. Neurons were pretreated for 3 h with cell-permeable
inhibitors of calpains and subsequently for 2 h with Palm29pen.
Cell survival in the presence of NGF was monitored for a further
17 h. Pretreatment of neurons with the calpain inhibitors
N-acetyl-Leu-Leu-norleucinal (data not shown) and PD150606
(Fig. 7A) prevented
Palm29pen-mediated cell death in a dose-dependent manner.
This indicates that calpain participates in the Chopper-mediated death
pathway.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
p75NTR death pathway components
include calpain and caspases. Sensory neuronal cell death induced
by 2-h treatment with 1 µM Palm29pen was prevented, in a
dose-dependent fashion, by a 3-h pretreatment with the
calpain inhibitor PD150606 (A) or the caspase
inhibitors t-butoxycarbonyl-D-fmk (BocD-fmk) and
benzyloxycarbonyl-DEVD-fmk (zDEVD-fmk) (B).
The number of live cells, grown in NGF, was counted prior to peptide
treatment (t = 0), and then cell death was determined
17 h after removal of peptides. The graphs have been standardized
to show c29pen cell death as 0% (mean ± S.E., n = 3).
|
|
Caspases have previously been shown to be a necessary component of the
p75NTR death pathway (16, 25, 48). To ascertain whether
caspases as well as calpains are a component of the Chopper death
pathway, cell-permeable peptide inhibitors of caspases were employed
(49). Neurons were treated with t-butoxycarbonyl-D-fmk or
benzyloxycarbonyl-DEVD-fmk (50) and subsequently treated with Palm29pen
as described above. Pretreatment of neurons with caspase inhibitors
prevented Palm29pen-mediated cell death in a dose-dependent
manner (Fig. 7B). These results indicate that Chopper
requires activation of caspases that cleave the DEVD sequence, namely
caspase-2, -3, and -7, for execution of cell death.
 |
DISCUSSION |
A New p75NTR Death Domain:Chopper--
The study has
identified a juxtamembrane 29-amino acid region of p75NTR
as being both required for and sufficient to induce rapid cell death.
This region, along with the transmembrane region, is the most highly
conserved sequence of p75NTR: 95% identity between rat,
human, and chicken (47). It is not, however, conserved between other
members of the TNFR/CD95 family of death receptors and shows little
sequence homology to other known protein domains. The region does,
however, contain a PEST sequence (residues 287-300), a region rich in
proline, aspartate, glutamate, serine, and threonine residues flanked
by clusters rich in basic amino acids, which has traditionally been
associated with accelerated protein degradation through facilitating
interactions with other molecules (see below for further discussion)
(51). This new juxtamembrane death-promoting region of
p75NTR has been named Chopper to distinguish it from the
putative death domain previously ascribed to p75NTR on the
basis of its homology to the death-activating domains, especially type
II found in the TNFR/CD95 receptor family (26). Our finding confirms
work demonstrating that p75NTR does not contain a domain
that functions in the same manner as the Fas receptor death domain (16,
28). The inhibition of p75NTR-mediated developmental cell
death in the chick retina by free Chopper peptides was to a similar
extent as that previously demonstrated with anti-NGF or
anti-p75NTR antibodies (23) and further supports the idea
that the Chopper domain is involved in initiating downstream death
signaling. There remains the possibility, however, that motifs within
the death domain may contribute to death signaling in particular
circumstances (52, 53).
Downstream Signaling through Chopper--
Chopper was found to
initiate cell death only if attached to the plasma membrane through its
transmembrane region or if palmitoylated. In addition to targeting
Chopper to the membrane, palmitoylation of p75NTR may play
a more direct role in activation since mutation of cysteine 279 to
alanine, through which p75NTR is normally palmitoylated
(42), results in loss of killing function, despite Chopper being
localized to the membrane via the transmembrane domain. Palmitoylation
is a reversible post-translational modification, targeting proteins to
subregions of the plasma membrane known as lipid rafts (54, 55). For
instance, palmitoylation is required for Ras to localize to
lipid rafts, where it interacts with other membrane-localized signaling
proteins to initiate signal transduction pathways (56). Similarly,
lipid modification is required for the receptor clustering function of
the Rapsyn protein (57). By increasing the local concentration of
Chopper and accessory protein complexes, palmitoylation may, like
multimerization of Fas and TNFR (58, 59), lead to initiation of death
signaling. Palmitoylation has also been shown to promote high affinity
interactions (39) that may favor the association of the Chopper domain
with binding partners.
The ability of non-membrane-bound Chopper to inhibit in a variety of
p75NTR-mediated neural death models including developmental
cell death in vivo implies a dominant-negative mechanism
whereby both the membrane-bound form and the free form interact with
the same accessory protein(s). Possible unidentified interacting
partners include proteins that could be localized to the same lipid
microdomains as palmitoylated p75NTR (39, 60, 61). Free
Chopper peptides may prevent cell death by sequestering such proteins
in the cytoplasm and thus away from membrane-associated Chopper.
Candidates for the role of Chopper-interacting molecules are members of
the TRAF family, which have been shown to mediate both cell survival
and death signaling in non-neural cells (62, 63). The TRAF proteins are
also implicated in NGF signaling through p75NTR (7, 30, 64,
65). Co-immunoprecipitation studies have indicated that all six TRAF
proteins are associated with, but may not directly bind to,
p75NTR (16, 30, 31) and that the association is dependent
on neurotrophin binding in some cases (30, 31). Both TRAF4 and TRAF6
have been shown to associate with the juxtamembrane region, whereas TRAF2 bound to the carboxyl-terminal region. Closer examination using
deletion mutants showed that residues 300-315 of the juxtamembrane region of p75NTR were required for the interaction with
TRAF6 to occur (30). Since only 3 amino residues of this domain overlap
with the Chopper domain, TRAF6 is unlikely to be involved in downstream signaling.
Two zinc finger proteins, neurotrophin receptor interacting factor (32)
and SC-1 (33), have recently been shown to directly interact with the
juxtamembrane domain of p75NTR, and both have been shown to
translocate to the nucleus after NGF binding to p75NTR (32,
33). Although little is known about the gene targets of these
transcription factors, mice with a targeted deletion in neurotrophin
receptor interacting factor have been shown to have reduced levels of
neuronal death in the developing retina, suggesting that it plays a
role in mediating neuronal death (32) and thus may be downstream of Chopper.
Evidence herein suggested that calpain participates in the
p75NTR death pathway possibly by interacting directly or
indirectly with the PEST domain within Chopper. Calpains are a family
of calcium-activated cysteinyl/thiol transferases that are highly expressed in brain and that play a role in mediating neuronal apoptosis
and necrosis in several chronic neurodegenerative diseases, in neural
injury, and after ischemia (66). Calpain, in some cases, has been shown
to be more important than caspases in mediating in vitro
models of neuronal death (66, 67). Although their substrate recognition
sequence is different, activated calpains and caspases cleave a number
of common proteins important in apoptotic pathways and can also cleave
each other (66, 67). Thus, it is possible to inhibit calpain-initiated
death signaling with traditional blockers of caspases such as DEVD,
which inhibits caspase-2, -3, and -7 (50, 67), which we have shown to
abrogate the ability of Chopper to kill (this study and Refs. 16, 25, and 48). Therefore, both calpain and caspases may be
p75NTR-mediated cell death effectors within the same
signaling pathway.
It has recently been shown that p75NTR can regulate
cellular calcium levels, causing an influx of calcium into the cell
after NGF stimulation (68), suggesting that p75NTR may
interact with an ion channel or channel regulator. Furthermore, many
studies show that membrane localization of calpain is necessary for its
activation (66), which would explain the requirement for membrane
attachment for Chopper killing action. These data are in agreement with
our model whereby activation of p75NTR/Chopper leads to
calcium influx, activation of calpain, and rapid cell death. In
addition, calpain-mediated cell death is not prevented by
overexpression of Bcl-2 (67); and thus, calpain-mediated cell death is
consistent with our observation that Bcl-2 does not inhibit
p75NTR-mediated death and can, in some cases, promote this
death (16, 25).
Activation of Chopper--
One of the surprising findings was that
Chopper death signaling was substantially inhibited by the presence of
the ectodomain of p75NTR and that, in 293T cells, there was
no observable killing unless the ectodomain was removed. The ability of
NGF to override the death signal in Trk-expressing cells only when
p75NTR retained the ectodomain highlighted this and
suggested that the ectodomain regulates Chopper activity by controlling
receptor clustering or perhaps by regulating calcium influx. This
raised the question of whether removal of the p75NTR
ectodomain could be the cause of physiological activation.
A wide variety of cell-surface proteins (69-71), including
p75NTR (72-75), are released from the plasma membrane by
extracellular cleavage. Metalloproteases, which cleave at a specific
distance from the membrane rather than at sequence-specific sites, have been shown to be responsible in most cases (76, 77). p75NTR
cleavage is indeed inhibited by metalloprotease inhibitors (75), and
cleavage also correlates developmentally and temporally with p75NTR acting as a death inducer, e.g. after
sciatic nerve lesion (72, 75, 78, 79). Therefore, we propose that
truncation of p75NTR by proteolytic cleavage within the
ectodomain might be a physiological mechanism for activating the cell
killing ability of p75NTR. Cleavage of the ectodomain of
p75NTR would leave a truncated protein in the membrane
equivalent to the protein produced by the sptc152 construct, which we
have shown to be far more effective at inducing cell death than
full-length p75NTR. Activation of p75NTR death
signaling by removal of the ectodomain may explain the perceived
paradoxical circumstances where p75NTR induces death
because a variety of environmental and developmental conditions, other
than Trk expression or ligand activation, might regulate
p75NTR cleavage (75, 80).
Conclusion--
A truncated protein containing the juxtamembrane
29-amino acid p75NTR sequence was shown to be capable of
inducing cell death when linked to the plasma membrane and was active
in a number of cell death paradigms. Evidence was provided that
the death pathway, which did not require Trk signaling, was likely to
be activated by binding of accessory proteins (present in a variety of
cell types) to the juxtamembrane domain, resulting in caspase and
calpain activation. It is proposed that physiological activation of the p75NTR death pathway might be due to ectodomain cleavage of
p75NTR, releasing a soluble ectodomain and yielding a
death-inducing, transmembrane-linked form of p75NTR.
 |
FOOTNOTES |
*
This work was supported by the National Health and Medical
Research Council of Australia, the Motor Neuron Disease Association of
Australia, and Parkinson's Victoria Inc.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 61-3-9345-2538;
Fax: 61-3-9347-0852; E-mail: coulson@wehi.edu.au.
Published, JBC Papers in Press, July 5, 2000, DOI 10.1074/jbc.M005214200
2
Oligonucleotide sequences are available on request.
 |
ABBREVIATIONS |
The abbreviations used are:
TNFR, tumor necrosis
factor receptor;
NGF, nerve growth factor;
GFP, green fluorescent
protein;
FACS, fluorescent-activated cell sorting;
Fmoc, N-(9-fluorenyl)methoxycarbonyl;
HPLC, high pressure
liquid chromatography;
fmk, fluoromethyl ketone;
E, embryonic
day;
LIF, leukemia inhibitory factor;
TRAF, TNFR-associated
factor.
 |
REFERENCES |
| 1.
|
Johnson, D.,
Lanahan, A.,
Buck, C. R.,
Sehgal, A.,
Morgan, C.,
Mercer, E.,
Bothwell, M.,
and Chao, M.
(1986)
Cell
47,
545-554
|
| 2.
|
Rodriguez-Tebar, A.,
Dechant, G.,
and Barde, Y. A.
(1990)
Neuron
4,
487-492
|
| 3.
|
Rodriguez-Tebar, A.,
Dechant, G.,
Gotz, R.,
and Barde, Y. A.
(1992)
EMBO J.
11,
917-922
|
| 4.
|
Meakin, S. O.,
and Shooter, E. M.
(1992)
Trends Neurosci.
15,
323-331
|
| 5.
|
Kaplan, D. R.,
and Miller, F. D.
(1997)
Curr. Opin. Cell Biol.
9,
213-221
|
| 6.
|
Hempstead, B. L.,
Patil, N.,
Thiel, B.,
and Chao, M. V.
(1990)
J. Biol. Chem.
265,
9595-9598
|
| 7.
|
Carter, B. D.,
Kaltschmidt, C.,
Kaltschmidt, B.,
Offenhauser, N.,
Bohm- Matthaei, R.,
Baeuerle, P. A.,
and Barde, Y. A.
(1996)
Science
272,
542-545
|
| 8.
|
Casaccia-Bonnefil, P.,
Carter, B. D.,
Dobrowsky, R. T.,
and Chao, M. V.
(1996)
Nature
383,
716-719
|
| 9.
|
Ladiwala, U.,
Lachance, C.,
Simoneau, S. J.,
Bhakar, A.,
Barker, P. A.,
and Antel, J. P.
(1998)
J. Neurosci.
18,
1297-1304
|
| 10.
|
Yoon, S. O.,
Casaccia-Bonnefil, P.,
Carter, B.,
and Chao, M. V.
(1998)
J. Neurosci.
18,
3273-3281
|
| 11.
|
Bamji, S. X.,
Majdan, M.,
Pozniak, C. D.,
Belliveau, D. J.,
Aloyz, R.,
Kohn, J.,
Causing, C. G.,
and Miller, F. D.
(1998)
J. Cell Biol.
140,
911-923
|
| 12.
|
Brann, A. B.,
Scott, R.,
Neuberger, Y.,
Abulafia, D.,
Boldin, S.,
Fainzilber, M.,
and Futerman, A. H.
(1999)
J. Neurosci.
19,
8199-8206
|
| 13.
|
Dobrowsky, R. T.,
Werner, M. H.,
Castellino, A. M.,
Chao, M. V.,
and Hannun, Y. A.
(1994)
Science
265,
1596-1599
|
| 14.
|
Rabizadeh, S.,
Oh, J.,
Zhong, L. T.,
Yang, J.,
Bitler, C. M.,
Butcher, L. L.,
and Bredesen, D. E.
(1993)
Science
261,
345-348
|
| 15.
|
Barrett, G. L.,
and Georgiou, A.
(1996)
J. Neurosci. Res.
45,
117-128
|
| 16.
|
Coulson, E. J.,
Reid, K.,
Barrett, G. L.,
and Bartlett, P. F.
(1999)
J. Biol. Chem.
274,
16387-16391
|
| 17.
|
Majdan, M.,
Lachance, C.,
Gloster, A.,
Aloyz, R.,
Zeindler, C.,
Bamji, S.,
Bhakar, A.,
Belliveau, D.,
Fawcett, J.,
Miller, F. D.,
and Barker, P. A.
(1997)
J. Neurosci.
17,
6988-6998
|
| 18.
|
Barrett, G. L.,
and Bartlett, P. F.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6501-6505
|
| 19.
|
Cheema, S. S.,
Barrett, G. L.,
and Bartlett, P. F.
(1996)
J. Neurosci. Res.
46,
239-245
|
| 20.
|
Ferri, C. C.,
Moore, F. A.,
and Bisby, M. A.
(1998)
J. Neurobiol.
34,
1-9
|
| 21.
|
von Bartheld, C. S.,
Kinoshita, Y.,
Prevette, D.,
Yin, Q. W.,
Oppenheim, R. W.,
and Bothwell, M.
(1994)
Neuron
12,
639-654
|
| 22.
|
Frade, J. M.,
and Barde, Y. A.
(1998)
Neuron
20,
35-41
|
| 23.
|
Frade, J. M.,
Rodriguez-Tebar, A.,
and Barde, Y. A.
(1996)
Nature
383,
166-168
|
| 24.
|
Davey, F.,
and Davies, A. M.
(1998)
Curr. Biol.
8,
915-918
|
| 25.
|
Soilu-Hänninen, M.,
Ekert, P.,
Bucci, T.,
Syroid, D.,
Bartlett, P. F.,
and Kilpatrick, T. J.
(1999)
J. Neurosci.
19,
4828-4838
|
| 26.
|
Feinstein, E.,
Kimchi, A.,
Wallach, D.,
Boldin, M.,
and Varfolomeev, E.
(1995)
Trends Biochem. Sci.
20,
342-344
|
| 27.
|
Liepinsh, E.,
Ilag, L. L.,
Otting, G.,
and Ibanez, C. F.
(1997)
EMBO J.
16,
4999-5005
|
| 28.
|
Kong, H.,
Kim, A. H.,
Orlinick, J. R.,
and Chao, M. V.
(1999)
Cell Death Differ.
6,
1133-1142
|
| 29.
|
Coulson, E. J.,
Reid, K.,
and Bartlett, P. F.
(1999)
Mol. Neurobiol.
20,
29-44
|
| 30.
|
Khursigara, G.,
Orlinick, J. R.,
and Chao, M. V.
(1999)
J. Biol. Chem.
274,
2597-2600
|
| 31.
|
Ye, X.,
Mehlen, P.,
Rabizadeh, S.,
VanArsdale, T.,
Zhang, H.,
Shin, H.,
Wang, J. J.,
Leo, E.,
Zapata, J.,
Hauser, C. A.,
Reed, J. C.,
and Bredesen, D. E.
(1999)
J. Biol. Chem.
274,
30202-30208
|
| 32.
|
Casademunt, E.,
Carter, B. D.,
Benzel, I.,
Frade, J. M.,
Dechant, G.,
and Barde, Y. A.
(1999)
EMBO J.
18,
6050-6061
|
| 33.
|
Chittka, A.,
and Chao, M. V.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
10705-10710
|
| 34.
|
Monuki, E. S.,
Kuhn, R.,
and Lemke, G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
9978-9982
|
| 35.
|
Derossi, D.,
Chassaing, G.,
and Prochiantz, A.
(1998)
Trends Cell Biol.
8,
84-87
|
| 36.
|
Frade, J. M.,
Bovolenta, P.,
Martinez-Morales, J. R.,
Arribas, A.,
Barbas, J. A.,
and Rodriguez-Tebar, A.
(1997)
Development
124,
3313-3320
|
| 37.
|
Papini, E.,
Rappuoli, R.,
Murgia, M.,
and Montecucco, C.
(1993)
J. Biol. Chem.
268,
1567-1574
|
| 38.
|
Shahinian, S.,
and Silvius, J. R.
(1995)
Biochemistry
34,
3813-3822
|
| 39.
|
Dunphy, J. T.,
and Linder, M. E.
(1998)
Biochim. Biophys. Acta
1436,
245-261
|
| 40.
|
Pittman, R. N.,
Wang, S.,
DiBenedetto, A. J.,
and Mills, J. C.
(1993)
J. Neurosci.
13,
3669-3680
|
| 41.
|
Kumar, S.,
and Lavin, M. F.
(1996)
Cell Death Differ.
3,
255-267
|
| 42.
|
Barker, P. A.,
Barbee, G.,
Misko, T. P.,
and Shooter, E. M.
(1994)
J. Biol. Chem.
269,
30645-30650
|
| 43.
|
Meakin, S. O.,
Suter, U.,
Drinkwater, C. C.,
Welcher, A. A.,
and Shooter, E. M.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
2374-2378
|
| 44.
|
Zaheer, A.,
Zhong, W.,
and Lim, R.
(1995)
Neurochem. Res.
20,
1457-1463
|
| 45.
|
Syroid, D. E.,
Maycox, P. J.,
Soilu-Hänninen, M.,
Petros, S.,
Bucci, T.,
Burrola, P.,
Murray, S.,
Cheema, S.,
Lee, K. F.,
Lemke, G.,
and Kilpatrick, T. J.
(2000)
J. Neurosci.
20,
5741-5747
|
| 46.
|
Shumway, S. D.,
Maki, M.,
and Miyamoto, S.
(1999)
J. Biol. Chem.
274,
30874-30881
|
| 47.
|
Large, T. H.,
Weskamp, G.,
Helder, J. C.,
Radeke, M. J.,
Misko, T. P.,
Shooter, E. M.,
and Reichardt, L. F.
(1989)
Neuron
2,
1123-1134
|
| 48.
|
Gu, C.,
Casaccia-Bonnefil, P.,
Srinivasan, A.,
and Chao, M. V.
(1999)
J. Neurosci.
19,
3043-3049
|
| 49.
|
Nicholson, D. W.,
and Thornberry, N. A.
(1997)
Trends Biochem. Sci.
22,
299-306
|
| 50.
|
Thornberry, N. A.,
Rano, T. A.,
Peterson, E. P.,
Rasper, D. M.,
Timkey, T.,
Garcia-Calvo, M.,
Houtzager, V. M.,
Nordstrom, P. A.,
Roy, S.,
Vaillancourt, J. P.,
Chapman, K. T.,
and Nicholson, D. W.
(1997)
J. Biol. Chem.
272,
17907-17911
|
| 51.
|
Chevaillier, P.
(1993)
Int. J. Biochem.
25,
479-482
|
| 52.
|
Hileman, M. R.,
Chapman, B. S.,
Rabizadeh, S.,
Krishnan, V. V.,
Bredesen, D.,
Assa-Munt, N.,
and Plesniak, L. A.
(1997)
FEBS Lett.
415,
145-154
|
| 53.
|
Mukai, J.,
Hachiya, T.,
Shoji-Hoshino, S.,
Kimura, M. T.,
Nadano, D.,
Suvanto, P.,
Hanaoka, T.,
Li, Y.,
Irie, S.,
Greene, L. A.,
and Sato, T. A.
(2000)
J. Biol. Chem.
275,
17566-17570
|
| 54.
|
Hooper, N. M.
(1998)
Curr. Biol.
8,
R114-R1146
|
| 55.
|
Simons, K.,
and Ikonen, E.
(1997)
Nature
387,
569-572
|
| 56.
|
Niv, H.,
Gutman, O.,
Henis, Y. I.,
and Kloog, Y.
(1999)
J. Biol. Chem.
274,
1606-1613
|
| 57.
|
Ramarao, M. K.,
and Cohen, J. B.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4007-4012
|
| 58.
|
Spencer, D. M.,
Belshaw, P. J.,
Chen, L.,
Ho, S. N.,
Randazzo, F.,
Crabtree, G. R.,
and Schreiber, S. L.
(1996)
Curr. Biol.
6,
839-847
|
| 59.
|
Ashkenazi, A.,
and Dixit, V. M.
(1998)
Science
281,
1305-1308
|
| 60.
|
Dunphy, J. T.,
Greentree, W. K.,
Manahan, C. L.,
and Linder, M. E.
(1996)
J. Biol. Chem.
271,
7154-7159
|
| 61.
|
Huang, C.,
Zhou, J.,
Feng, A. K.,
Lynch, C. C.,
Klumperman, J.,
DeArmond, S. J.,
and Mobley, W. C.
(1999)
J. Biol. Chem.
274,
36707-36714
|
| 62.
|
Nishitoh, H.,
Saitoh, M.,
Mochida, Y.,
Takeda, K.,
Nakano, H.,
Rothe, M.,
Miyazono, K.,
and Ichijo, H.
(1998)
Mol. Cell
2,
389-395
|
| 63.
|
Liu, Z. G.,
Hsu, H.,
Goeddel, D. V.,
and Karin, M.
(1996)
Cell
87,
565-576
|
| 64.
|
Hamanoue, M.,
Middleton, G.,
Wyatt, S.,
Jaffray, E.,
Hay, R. T.,
and Davies, A. M.
(1999)
Mol. Cell. Neurosci.
14,
28-40
|
| 65.
|
Reinhard, C.,
Shamoon, B.,
Shyamala, V.,
and Williams, L. T.
(1997)
EMBO J.
16,
1080-1092
|
| 66.
|
Chan, S. L.,
and Mattson, M. P.
(1999)
J. Neurosci. Res.
58,
167-190
|
| 67.
|
Ruiz-Vela, A.,
Gonzalez de Buitrago, G.,
and Martinez, A. C.
(1999)
EMBO J.
18,
4988-4998
|
| 68.
|
Jiang, H.,
Takeda, K.,
Lazarovici, P.,
Katagiri, Y., Yu, Z. X.,
Dickens, G.,
Chabuk, A.,
Liu, X. W.,
Ferrans, V.,
and Guroff, G.
(1999)
J. Biol. Chem.
274,
26209-26216
|
| 69.
|
Arribas, J.,
Coodly, L.,
Vollmer, P.,
Kishimoto, T. K.,
Rose-John, S.,
and Massague, J.
(1996)
J. Biol. Chem.
271,
11376-11382
|
| 70.
|
Arribas, J.,
and Massague, J.
(1995)
J. Cell Biol.
128,
433-441
|
| 71.
|
Merlos-Suarez, A.,
Fernandez-Larrea, J.,
Reddy, P.,
Baselga, J.,
and Arribas, J.
(1998)
J. Biol. Chem.
273,
24955-24962
|
| 72.
|
DiStefano, P. S.,
and Johnson, E. M., Jr.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
270-274
|
| 73.
|
Zupan, A. A.,
Osborne, P. A.,
Smith, C. E.,
Siegel, N. R.,
Leimgruber, R. M.,
and Johnson, E. M., Jr.
(1989)
J. Biol. Chem.
264,
11714-11720
|
| 74.
|
Barker, P. A.,
Miller, F. D.,
Large, T. H.,
and Murphy, R. A.
(1991)
J. Biol. Chem.
266,
19113-19119
|
| 75.
|
DiStefano, P. S.,
Chelsea, D. M.,
Schick, C. M.,
and McKelvy, J. F.
(1993)
J. Neurosci.
13,
2405-2414
|
| 76.
|
Tang, P.,
Hung, M. C.,
and Klostergaard, J.
(1996)
Biochemistry
35,
8226-8233
|
| 77.
|
Arribas, J.,
Lopez-Casillas, F.,
and Massague, J.
(1997)
J. Biol. Chem.
272,
17160-17165
|
| 78.
|
DiStefano, P. S.,
Clagett-Dame, M.,
Chelsea, D. M.,
and Loy, R.
(1991)
Ann. Neurol.
29,
13-20
|
| 79.
|
Lindner, M. D.,
Gordon, D. D.,
Miller, J. M.,
Tariot, P. N.,
McDaniel, K. D.,
Hamill, R. W.,
DiStefano, P. S.,
and Loy, R.
(1993)
Arch. Neurol.
50,
1054-1060
|
| 80.
|
Roghani, M.,
Becherer, J. D.,
Moss, M. L.,
Atherton, R. E.,
Erdjument- Bromage, H.,
Arribas, J.,
Blackburn, R. K.,
Weskamp, G.,
Tempst, P.,
and Blobel, C. P.
(1999)
J. Biol. Chem.
274,
3531-3540
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Caporali and C. Emanueli
Cardiovascular Actions of Neurotrophins
Physiol Rev,
January 1, 2009;
89(1):
279 - 308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sotthibundhu, A. M. Sykes, B. Fox, C. K. Underwood, W. Thangnipon, and E. J. Coulson
{beta}-Amyloid1-42 Induces Neuronal Death through the p75 Neurotrophin Receptor
J. Neurosci.,
April 9, 2008;
28(15):
3941 - 3946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Coulson, L. M. May, S. L. Osborne, K. Reid, C. K. Underwood, F. A. Meunier, P. F. Bartlett, and P. Sah
p75 Neurotrophin Receptor Mediates Neuronal Cell Death by Activating GIRK Channels through Phosphatidylinositol 4,5-Bisphosphate
J. Neurosci.,
January 2, 2008;
28(1):
315 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tan and R. K. Shepherd
Aminoglycoside-Induced Degeneration of Adult Spiral Ganglion Neurons Involves Differential Modulation of Tyrosine Kinase B and p75 Neurotrophin Receptor Signaling
Am. J. Pathol.,
August 1, 2006;
169(2):
528 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Ahmed, E. L. Suggate, E. R. Brown, R. G. Dent, S. J. Armstrong, L. B. Barrett, M. Berry, and A. Logan
Schwann cell-derived factor-induced modulation of the NgR/p75NTR/EGFR axis disinhibits axon growth through CNS myelin in vivo and in vitro
Brain,
June 1, 2006;
129(6):
1517 - 1533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Aurikko, B. T. Ruotolo, J. G. Grossmann, M. C. Moncrieffe, E. Stephens, V.-M. Leppanen, C. V. Robinson, M. Saarma, R. A. Bradshaw, and T. L. Blundell
Characterization of Symmetric Complexes of Nerve Growth Factor and the Ectodomain of the Pan-neurotrophin Receptor, p75NTR
J. Biol. Chem.,
September 30, 2005;
280(39):
33453 - 33460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Florez-McClure, D. A. Linseman, C. T. Chu, P. A. Barker, R. J. Bouchard, S. S. Le, T. A. Laessig, and K. A. Heidenreich
The p75 Neurotrophin Receptor Can Induce Autophagy and Death of Cerebellar Purkinje Neurons
J. Neurosci.,
May 12, 2004;
24(19):
4498 - 4509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. BREDESEN, P. MEHLEN, and S. RABIZADEH
Apoptosis and Dependence Receptors: A Molecular Basis for Cellular Addiction
Physiol Rev,
April 1, 2004;
84(2):
411 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Kuwako, H. Taniura, and K. Yoshikawa
Necdin-related MAGE Proteins Differentially Interact with the E2F1 Transcription Factor and the p75 Neurotrophin Receptor
J. Biol. Chem.,
January 16, 2004;
279(3):
1703 - 1712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mehlen and D. E. Bredesen
Meeting Report: Cellular Dependence--Old Concept, New Mechanisms
Sci. Signal.,
December 16, 2003;
2003
(213):
pe55 - pe55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Chao
Dependence Receptors: What Is the Mechanism?
Sci. Signal.,
September 16, 2003;
2003(200):
pe38 - pe38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. O'Leary and R. A. Hughes
Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor
J. Biol. Chem.,
July 3, 2003;
278(28):
25738 - 25744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Kanning, M. Hudson, P. S. Amieux, J. C. Wiley, M. Bothwell, and L. C. Schecterson
Proteolytic Processing of the p75 Neurotrophin Receptor and Two Homologs Generates C-Terminal Fragments with Signaling Capability
J. Neurosci.,
July 2, 2003;
23(13):
5425 - 5436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Williams, P. Strickland, K. Watanabe, and L. Hinck
UNC5H1 Induces Apoptosis via Its Juxtamembrane Region through an Interaction with NRAGE
J. Biol. Chem.,
May 2, 2003;
278(19):
17483 - 17490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Troy, J. E. Friedman, and W. J. Friedman
Mechanisms of p75-mediated Death of Hippocampal Neurons. ROLE OF CASPASES
J. Biol. Chem.,
September 6, 2002;
277(37):
34295 - 34302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Jover, H. Tanaka, A. Calderone, K. Oguro, M. V. L. Bennett, A. M. Etgen, and R. S. Zukin
Estrogen Protects against Global Ischemia-Induced Neuronal Death and Prevents Activation of Apoptotic Signaling Cascades in the Hippocampal CA1
J. Neurosci.,
March 15, 2002;
22(6):
2115 - 2124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Khursigara, J. Bertin, H. Yano, H. Moffett, P. S. DiStefano, and M. V. Chao
A Prosurvival Function for the p75 Receptor Death Domain Mediated via the Caspase Recruitment Domain Receptor-Interacting Protein 2
J. Neurosci.,
August 15, 2001;
21(16):
5854 - 5863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, J. H. Bauer, Y. Li, Z. Shao, F. S. Zetoune, E. Cattaneo, and C. Vincenz
Characterization of a p75NTR Apoptotic Signaling Pathway Using a Novel Cellular Model
J. Biol. Chem.,
August 31, 2001;
276(36):
33812 - 33820.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|